Natixis Advisors
PRAH

Natixis Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Natixis Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-62,476
Closed -$7.84M – 1310
2020
Q4 		$7.84M Buy
62,476
+5,389
+9% +$603K 0.05% 424
2020
Q3 		$5.79M Buy
57,087
+10,882
+24% +$1.11M 0.04% 473
2020
Q2 		$4.5M Sell
46,205
-9,316
-17% -$867K 0.03% 547
2020
Q1 		$4.61M Buy
55,521
+11,110
+25% +$1.08M 0.04% 477
2019
Q4 		$4.94M Buy
44,411
+3,850
+9% +$396K 0.03% 532
2019
Q3 		$4.03M Buy
40,561
+12,921
+47% +$1.28M 0.03% 554
2019
Q2 		$2.74M Buy
27,640
+5,057
+22% +$483K 0.02% 676
2019
Q1 		$2.49M Sell
22,583
-724
-3% -$75.7K 0.02% 690
2018
Q4 		$2.14M Sell
23,307
-8,201
-26% -$830K 0.02% 691
2018
Q3 		$3.47M Sell
31,508
-6,021
-16% -$627K 0.03% 599
2018
Q2 		$3.5M Sell
37,529
-6,986
-16% -$602K 0.03% 587
2018
Q1 		$3.69M Sell
44,515
-1,065
-2% -$94.6K 0.04% 548
2017
Q4 		$4.15M Sell
45,580
-1,891
-4% -$157K 0.04% 480
2017
Q3 		$3.62M Buy
47,471
+7,693
+19% +$581K 0.04% 535
2017
Q2 		$2.98M Sell
39,778
-1,629
-4% -$113K 0.03% 593
2017
Q1 		$2.7M Sell
41,407
-17,507
-30% -$1.03M 0.03% 622
2016
Q4 		$3.25M Buy
58,914
+5,887
+11% +$323K 0.04% 534
2016
Q3 		$3M Buy
53,027
+228
+0.4% +$11.2K 0.04% 551
2016
Q2 		$2.2M Sell
52,799
-1
-0% -$46 0.03% 603
2016
Q1 		$2.26M Sell
52,800
-28,176
-35% -$1.19M 0.03% 594
2015
Q4 		$3.67M Sell
80,976
-106,505
-57% -$4.47M 0.06% 424
2015
Q3 		$7.28M Sell
187,481
-39,890
-18% -$1.6M 0.13% 212
2015
Q2 		$8.26M Buy
227,371
+33,462
+17% +$1.06M 0.14% 193
2015
Q1 		$5.59M Sell
193,909
-4,181
-2% -$117K 0.1% 308
2014
Q4 		$4.8M Buy
+198,090
New +$4.46M 0.09% 344

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Natixis Advisors's PRAH Position: Q1 2021 in Review

Natixis Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 62,476 shares — an estimated $7.84M sold.

Natixis Advisors first reported a position in PRAH in Q4 2014 and held it in 25 quarters. The position peaked at $8.26M in Q2 2015. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Natixis Advisors reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Natixis Advisors sold 62,476 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $7.84M.
  • Natixis Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 25 quarters.
  • Natixis Advisors's PRA Health Sciences, Inc. position peaked at $8.26M in Q2 2015.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Natixis Advisors's 13F filing for Q1 2021, filed 5 May 2021.